Heart disease may soon go the way of typhoid, polio and hepatitis, if researchers at La Jolla Institute for Allergy and Immunology have their way. The school recently published a study showing that we are closer than ever to stopping, once and for all, the cardiovascular disorders that develop throughout people’s lives.
The idea of a heart disease vaccine would be groundbreaking for cardiac center panama city FL. In the United States, cardiovascular diseases top the charts for leading causes of death. But soon there may be relief as La Jolla researchers from believe they be able to create a vaccine that can combat heart disease.
This will all be possible through the creation of a tolerogenic vaccine that will function by inducing tolerance in the body to halt any inflammatory attack may soon be conceivable. Researchers have singled out CD4 T-cells, which orchestrate the inflammatory attacks on the artery wall, and plan to direct the vaccine directly on their hazardous activity.
According to researchers, it wasn’t previously known that antigen-experienced T cells existed in the vessel wall. The experiment points some experts towards the possibility of building a vaccine for heart disease.
Yet health experts are warning that creating a vaccine is a time-consuming and difficult process that may take several years to develop. Regardless, the meer posibility of such a vaccine is exciting many with the possibility of saving more lives than ever imaginable.
Antigen is a conventional protein that the body detects as a foreign source, and consequently launches an immune system attack, resulting in inflammation in the arteries. According to researchers, the attacks is what causes the inflammation among the vessels in the wall persistent. The inflammation cells join the fat and cholesterol form artery-clogging plaque that eventually blocks the blood flow and triggers a heart attack.
If the researchers at La Jolla can target the source of these inflammation attacks, they might make heart attacks, like polio, a thing of the past.